Not finding it? Sign in to also search OpenAlex live.
-
Abstract PD2-11: Breast cancer index is a molecular signature of endocrine responsiveness that determines extended endocrine benefit independent of prognostic risk2021 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Gerrit‐Jan Liefers, Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Jenna Wong, +4 more
0citations -
Abstract P2-11-10: Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
John M.S. Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, +12 more
0citations -
Prognostic Interaction Between Inflammatory and Clinical Risk Factors for Asthma Attacks: Findings from the ORACLE2 Patient-level Meta-analysis2025 American Journal of Respiratory and Critical Care Medicine conference-abstract Medicine Asthma and respiratory diseases
Samuel Mailhot-Larouche, Fleur L. Meulmeester, Philippe Lachapelle, Carlos Andrés Celis-Preciado, Samuel Lemaire‐Paquette, Sanjay Ramakrishnan, +21 more
1citations -
Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR+ breast cancer in the TEAM trial.2023 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
John M.S. Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, +12 more
1citations -
Abstract 1727: CD8+ T cells in the invasive margin combined with FOXP3+ T cells in the tumor center significantly associate with survival in resectable gastric cancer, a post-hoc analysis of the Dutch D1/D2 trial
Tanya T.D. Soeratram, Hedde D. Biesma, Jacqueline Egthuijsen, Elma Meershoek‐Klein Kranenbarg, Henk H. Hartgrink, Cornelis JH van de Velde, +5 more
0citations -
The prognostic performance of PREDICT+ in patients (pts) with HER2-positive (HER2+) early-stage breast cancer (EBC).2021 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Georges Aftimos, Noam Falbel Ponde, Christian Maurer, +14 more
1citations -
P18.02.B ANALYSIS OF TUMOR RELAPSE PROBABILITY AND OVERALL SURVIVAL PREDICTION FOLLOWING CONCOMITANT RADIOTHERAPY WITH TEMOZOLOMIDE USING FET PET IN PATIENTS WITH GLIOBLASTOMA
Isabelle Stetter, Jan‐Michael Werner, Michael Wollring, Garry S. Ceccon, Philipp Lohmann, Gabriele Stoffels, +4 more
0citations -
Prediction of Poor Survival after Hematopoietic Cell Transplantation in Myelofibrosis Using Machine Learning Techniques2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Juan Carlos Hernández‐Boluda, Adrián Mosquera Orgueira, Luuk A. Gras, Linda Köster, Joe Tuffnell, Nicolaus Martin Kröger, +24 more
1citations -
Abstract P1-10-01: Caveolin gene expression predicts for response and clinical outcomes of patients treated with preoperative paclitaxel-based chemotherapy regimens in early stage breast cancer2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Terence Marques Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten Ernst Weber, Peter Andreas Fasching, +16 more
0citations -
Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1-Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients
Marius Bill, Jan‐Niklas Eckardt, Christian R. Rausch, Klaus Hans Metzeler, Karsten Spiekermann, Sebastian Stasik, +34 more
3citations -
Abstract P2-03-13: Breast Cancer Index (BCI) identifies fewer patients with high risk of late recurrence and high likelihood of benefit from extended endocrine therapy with invasive lobular compared to invasive ductal carcinoma2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Otto Metzger, Neeta Parimi, Natalia Siuliukina, Yi Zhang, Kai Treuner, Gerrit‐Jan Liefers
3citations -
The prognostic value of tumor markers in patients (pts) with resectable gastric cancer (GC) receiving perioperative therapy in the CRITICS trial.2021 Journal of Clinical Oncology conference-abstract Medicine Gastric Cancer Management and Outcomes
Astrid E. Slagter, Marieke A. Vollebergh, Irene A. Caspers, Johanna Wilhelmina van Sandick, Karolina Sikorska, Pehr Lind, +10 more
0citations -
Abstract PD6-11: PD6-11 Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program
Danielle Brandes Zakon, Coralie Poncet, Fátima Cardoso, Neven Anouk, Vicente Valero, Stefan Paul Aebi, +28 more
0citations